Australia, Sept. 12 -- AMBRY GENETICS Corp., owns the trademark (2632733) for 'CANCERNEXT' till Feb. 3, 2036.
Status: protected:
Registered/protected
Class: 44 [Medical screening; medical testing services for diagnostic or treatment purposes; DNA screening for medical purposes.]
Type of Mark: Word
Date of Acceptance: April 23
Registration Advertised: Sept. 11
For further details contact Carrie L. Kiedrowski Jones Day.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2632733.
Disclaimer: Curated by HT Syndication.
